Study of Duvelisib in Combination With Rituximab vs Rituximab in Subjects With Previously Treated Follicular Lymphoma

NCT02204982 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

13

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor is focusing on studies which can enable registration of duvelisib

Conditions

Follicular Lymphoma

Interventions

DRUG: Duvelisib
DRUG: Placebo
DRUG: Rituximab

Sponsor

SecuraBio